CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,940 Cr | ₹5,005 Cr | ₹4,134 Cr | ₹3,238 Cr | ₹3,326 Cr |
What is the latest Cash Flow from Operating Activities ratio of CIPLA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,940 Cr |
| Mar2025 | ₹5,005 Cr |
| Mar2024 | ₹4,134 Cr |
| Mar2023 | ₹3,238 Cr |
| Mar2022 | ₹3,326 Cr |
How is Cash Flow from Operating Activities of CIPLA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,940 Cr | -21.28 | |
| Mar2025 | ₹5,005 Cr | 21.07 | |
| Mar2024 | ₹4,134 Cr | 27.68 | |
| Mar2023 | ₹3,238 Cr | -2.65 | |
| Mar2022 | ₹3,326 Cr | - | |
Compare Cash Flow from Operating Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,812.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| MANKIND PHARMA | ₹104,376.0 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.6% |
-5% |
-10.6% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses